We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$77.9B
AUM Growth
+$4.06B
Cap. Flow
-$1.94B
Cap. Flow %
-2.49%
Top 10 Hldgs %
9.87%
Holding
2,618
New
119
Increased
915
Reduced
1,382
Closed
132

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Industrials 12.2%
3 Healthcare 12.13%
4 Consumer Discretionary 11.81%
5 Financials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
2251
Heron Therapeutics
HRTX
$71.6M
$201K ﹤0.01%
+13,577
New +$212K
PGNY icon
2252
Progyny
PGNY
$2.22B
$201K ﹤0.01%
+6,834
New +$188K
GFF icon
2253
Griffon
GFF
$4.71B
$200K ﹤0.01%
10,215
-22,885
-69% -$470K
CVM icon
2254
CEL-SCI Corp
CVM
$27.3M
$199K ﹤0.01%
520
-16
-3% -$6.31K
DBRG icon
2255
DigitalBridge
DBRG
$2.95B
$199K ﹤0.01%
18,205
-1,040
-5% -$10.1K
PGRE
2256
DELISTED
Paramount Group
PGRE
$197K ﹤0.01%
27,851
-1,604
-5% -$11.7K
GOOD
2257
Gladstone Commercial Corp
GOOD
$618M
$196K ﹤0.01%
+11,614
New +$212K
BRKL
2258
DELISTED
Brookline Bancorp
BRKL
$195K ﹤0.01%
22,581
+11,170
+98% +$106K
SRNE
2259
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$194K ﹤0.01%
+17,381
New +$159K
NXGN
2260
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$193K ﹤0.01%
15,136
-1,500
-9% -$19.2K
CLLS
2261
Cellectis
CLLS
$269M
$191K ﹤0.01%
10,304
-4,356
-30% -$77.3K
EGHT icon
2262
8x8 Inc
EGHT
$328M
$191K ﹤0.01%
12,261
-2,725
-18% -$43.8K
CCO icon
2263
Clear Channel Outdoor Holdings
CCO
$1.23B
$185K ﹤0.01%
184,707
-1,198
-0.6% -$1.29K
RIG icon
2264
Transocean
RIG
$6.29B
$184K ﹤0.01%
227,976
+96,951
+74% +$158K
ATI icon
2265
ATI
ATI
$31.2B
$178K ﹤0.01%
20,449
-6,731
-25% -$62K
HOUS
2266
DELISTED
Anywhere Real Estate
HOUS
$176K ﹤0.01%
18,632
-1,533
-8% -$14.7K
IFS icon
2267
Intercorp Financial Services
IFS
$6.49B
$174K ﹤0.01%
7,515
DENN
2268
DELISTED
Denny's
DENN
$173K ﹤0.01%
17,345
-345,533
-95% -$3.46M
VNDA icon
2269
Vanda Pharmaceuticals
VNDA
$297M
$170K ﹤0.01%
+17,620
New +$188K
GRTS
2270
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$165K ﹤0.01%
62,350
-174,718
-74% -$649K
MDRX
2271
DELISTED
Veradigm Inc. Common Stock
MDRX
$164K ﹤0.01%
20,208
-1,930
-9% -$15.8K
ICAD
2272
DELISTED
iCAD Inc
ICAD
$162K ﹤0.01%
18,350
SIGA icon
2273
SIGA Technologies
SIGA
$207M
$162K ﹤0.01%
+23,556
New +$160K
SGMO
2274
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$161K ﹤0.01%
17,034
-1,205
-7% -$13K
WBT
2275
DELISTED
Welbilt, Inc.
WBT
$161K ﹤0.01%
26,057
+6,785
+35% +$45.7K

Similar funds

Victory Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Victory Capital Management held 2,618 positions worth $77.9B, up 5.5% from $73.8B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Victory Capital Management's Q3 2020 filing shows 119 new, 915 increased, 1,382 reduced and 132 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,734,130 shares worth $165M. The largest sale was Allstate, an estimated $226M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Victory Capital Management's largest Q3 2020 buy was iShares MSCI Emerging Markets ETF: 3,734,130 shares worth $165M.
  • Victory Capital Management added most to Hershey in Q3 2020, an estimated $185M increase.
  • Victory Capital Management's biggest Q3 2020 reduction was Allstate, cutting an estimated $226M.
  • Victory Capital Management fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2020, selling an estimated $170M.
  • Victory Capital Management's ten largest holdings make up 9.9% of its $77.9B portfolio in Q3 2020.
  • Victory Capital Management opened 119 new positions and closed 132 in Q3 2020.
  • Victory Capital Management's portfolio value rose 5.5% quarter-over-quarter to $77.9B.

Based on Victory Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.